| Title | Diabetes Technology and Therapeutics |
| Abbreviation | Diabetes Technol. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1) |
| h-index | 103 |
| Overall Rank/Ranking | 686 |
| SCImago Journal Rank (SJR) | 2.957 |
| Impact Score | 5.54 |
| Publisher | Mary Ann Liebert Inc. |
| Country | United States |
| ISSN | 15209156, 15578593 |
| Best Quartile | Q1 |
| Coverage History | 1999-2023 |
Diabetes Technology & Therapeutics is the only peer-reviewed journal that focuses on the use of new devices, drug delivery systems, and software for managing diabetes.
The field of diabetes management is rapidly evolving because of the introduction of recently engineered devices and drugs. This journal focuses on emerging applications of bioengineering tools for diabetes management, including the use of optics, material science, controlled drug release, tissue engineering, informatics, modeling, genomics, imagery, and microelectronic mechanical systems (MEMS).
Diabetes Technology & Therapeutics fosters the development and use of new and emerging technologies to be applied to diabetes.
Diabetes Technology and Therapeutics is a journal covering the technologies/fields/categories related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1). It is published by Mary Ann Liebert Inc.. The overall rank of Diabetes Technology and Therapeutics is 686. According to SCImago Journal Rank (SJR), this journal is ranked 2.957. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 103. The best quartile for this journal is Q1.
The ISSN of Diabetes Technology and Therapeutics journal is 15209156, 15578593. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Diabetes Technology and Therapeutics is cited by a total of 2292 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Diabetes Technology and Therapeutics is 5.54, which is computed in 2024 as per its definition. Diabetes Technology and Therapeutics IF is increased by a factor of 0.3 and approximate percentage change is 5.73% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Diabetes Technology and Therapeutics is 5.54. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5.54 |
| 2022 | 5.24 |
| 2021 | 5.43 |
| 2020 | 4.51 |
| 2019 | 4.26 |
| 2018 | 3.16 |
| 2017 | 1.65 |
| 2016 | 1.60 |
| 2015 | 1.50 |
| 2014 | 1.94 |
Diabetes Technology and Therapeutics has an h-index of 103. It means 103 articles of this journal have more than 103 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Diabetes Technology and Therapeutics is 15209156, 15578593. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Diabetes Technology and Therapeutics is 686. According to SCImago Journal Rank (SJR), this journal is ranked 2.957. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.957 |
| 2022 | 2.374 |
| 2021 | 2.660 |
| 2020 | 2.142 |
| 2019 | 1.819 |
| 2018 | 1.800 |
| 2017 | 1.735 |
| 2016 | 1.361 |
| 2015 | 1.245 |
| 2014 | 1.332 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 686 |
| 2022 | 986 |
| 2021 | 746 |
| 2020 | 1171 |
| 2019 | 1559 |
| 2018 | 1645 |
| 2017 | 1768 |
| 2016 | 2781 |
| 2015 | 3233 |
| 2014 | 2803 |
Diabetes Technology and Therapeutics is published by Mary Ann Liebert Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1999-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Diabetes Technology and Therapeutics is Diabetes Technol. Ther.. This abbreviation ('Diabetes Technol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Diabetes Technology and Therapeutics latest impact IF is 5.54. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.54 (2023) and 1.50 (2015), respectively, in the last 10 years. Moreover, its average IS is 3.48 in the previous 10 years.
The Diabetes Technology and Therapeutics has an SJR (SCImago Journal Rank) of 2.957, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.957 in 2023 and the lowest being 1.245 in 2015. Furthermore, the average SJR of the Diabetes Technology and Therapeutics over the previous 10-year period stands at 3.48.
The latest h-index of the Diabetes Technology and Therapeutics is 103.
The Diabetes Technology and Therapeutics is published by the Mary Ann Liebert Inc., with its country of publication being the United States.
The Diabetes Technology and Therapeutics is currently ranked 686 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 686 in 2023 and its lowest position of 3233 in 2015.
The standard ISO4 abbreviation for the Diabetes Technology and Therapeutics is Diabetes Technol. Ther..
Diabetes Technology and Therapeutics is classified as a journal that the Mary Ann Liebert Inc. publishes.
The Diabetes Technology and Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Diabetes Technology and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 15209156, 15578593.
The best quartile for the Diabetes Technology and Therapeutics is Q1 (2023).
The Diabetes Technology and Therapeutics coverage history can be summarized as follows: 1999-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Socialism and Democracy | journal | 25103 | Taylor and Francis Ltd. | 18 | 0.12 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 27272 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Journal of Imaging Science and Technology | journal | 17857 | Society for Imaging Science and Technology | 45 | 0.68 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| Transactions on Embedded Computing Systems | journal | 5892 | Association for Computing Machinery (ACM) | 64 | 2.87 |
| Journal of Evolutionary Psychology | journal | 28897 | Akademiai Kiado | 0 | 0.00 |
| Communications in Computational Physics | journal | 3404 | Global Science Press | 67 | 2.22 |
| Society and Economy | journal | 17871 | Akademiai Kiado | 16 | 0.87 |
| Revista de Administracao Publica | journal | 11911 | Fundacao Getulio Vargas | 23 | 1.08 |
| Health Economics, Policy and Law | journal | 4445 | Cambridge University Press | 44 | 3.13 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 5.54 |
| 2022 | 5.24 |
| 2021 | 5.43 |
| 2020 | 4.51 |
| 2019 | 4.26 |
| 2018 | 3.16 |
| 2017 | 1.65 |
| 2016 | 1.60 |
| 2015 | 1.50 |
| 2014 | 1.94 |
